Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.

<h4>Background/purpose</h4>An increased prevalence of non-alcoholic fatty liver disease (NAFLD) is observed in patients with inflammatory bowel disease (IBD) in Western countries. Both intestinal inflammation and metabolic factors contribute to the pathogenesis of IBD-associated NAFLD. T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/a36101caba7b4924a7de216557bb2e84
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a36101caba7b4924a7de216557bb2e84
record_format	dspace
spelling	oai:doaj.org-article:a36101caba7b4924a7de216557bb2e842021-11-25T06:23:42ZEvaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.1932-620310.1371/journal.pone.0252286https://doaj.org/article/a36101caba7b4924a7de216557bb2e842021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0252286https://doaj.org/toc/1932-6203<h4>Background/purpose</h4>An increased prevalence of non-alcoholic fatty liver disease (NAFLD) is observed in patients with inflammatory bowel disease (IBD) in Western countries. Both intestinal inflammation and metabolic factors contribute to the pathogenesis of IBD-associated NAFLD. The burden of NAFLD is not clear in the Asian population. This study aimed to evaluate the prevalence of NAFLD and liver fibrosis in a cohort of Taiwanese patients with IBD.<h4>Methods</h4>From January to December 2019, patients with IBD who underwent ultrasound examination were enrolled. Hepatic steatosis and fibrosis were measured with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) using FibroScan. Patients with a history of excessive alcohol or recent steroid use were excluded. Univariate and multivariate analysis were performed.<h4>Results</h4>A total of 81 consecutive patients were enrolled and included in the analysis (45 with ulcerative colitis, 36 with Crohn's disease). The median age was 42 years old. The patients were classified in terms of body mass index as normal weight (54.3%), underweight (11.1%), overweight (28.4%), and obese (6.2%). The mean CAP increased to 162.22 dB/m in the underweight group, 210.86 dB/m in the normal weight group, 260.7 dB/m in the overweight group, and 274.0 dB/m in the obese group. NAFLD was observed in 29.6% of the patients, 1.2% of which had significant fibrosis. Increased body mass index (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.1-1.62) and older age at IBD diagnosis (OR: 1.05, 95% CI 1-1.11) was found to be associated with the presence of NAFLD.<h4>Conclusion</h4>In this study, the prevalence of NAFLD was lower (29.6%) in IBD patients than in the Western population. Higher BMI and older age were associated with NAFLD in our study.Hsu-Heng YenPei-Yuan SuSiou-Ping HuangLisha WuTsui-Chun HsuYa-Huei ZengYang-Yuan ChenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 5, p e0252286 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Hsu-Heng Yen Pei-Yuan Su Siou-Ping Huang Lisha Wu Tsui-Chun Hsu Ya-Huei Zeng Yang-Yuan Chen Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
description	<h4>Background/purpose</h4>An increased prevalence of non-alcoholic fatty liver disease (NAFLD) is observed in patients with inflammatory bowel disease (IBD) in Western countries. Both intestinal inflammation and metabolic factors contribute to the pathogenesis of IBD-associated NAFLD. The burden of NAFLD is not clear in the Asian population. This study aimed to evaluate the prevalence of NAFLD and liver fibrosis in a cohort of Taiwanese patients with IBD.<h4>Methods</h4>From January to December 2019, patients with IBD who underwent ultrasound examination were enrolled. Hepatic steatosis and fibrosis were measured with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) using FibroScan. Patients with a history of excessive alcohol or recent steroid use were excluded. Univariate and multivariate analysis were performed.<h4>Results</h4>A total of 81 consecutive patients were enrolled and included in the analysis (45 with ulcerative colitis, 36 with Crohn's disease). The median age was 42 years old. The patients were classified in terms of body mass index as normal weight (54.3%), underweight (11.1%), overweight (28.4%), and obese (6.2%). The mean CAP increased to 162.22 dB/m in the underweight group, 210.86 dB/m in the normal weight group, 260.7 dB/m in the overweight group, and 274.0 dB/m in the obese group. NAFLD was observed in 29.6% of the patients, 1.2% of which had significant fibrosis. Increased body mass index (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.1-1.62) and older age at IBD diagnosis (OR: 1.05, 95% CI 1-1.11) was found to be associated with the presence of NAFLD.<h4>Conclusion</h4>In this study, the prevalence of NAFLD was lower (29.6%) in IBD patients than in the Western population. Higher BMI and older age were associated with NAFLD in our study.
format	article
author	Hsu-Heng Yen Pei-Yuan Su Siou-Ping Huang Lisha Wu Tsui-Chun Hsu Ya-Huei Zeng Yang-Yuan Chen
author_facet	Hsu-Heng Yen Pei-Yuan Su Siou-Ping Huang Lisha Wu Tsui-Chun Hsu Ya-Huei Zeng Yang-Yuan Chen
author_sort	Hsu-Heng Yen
title	Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
title_short	Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
title_full	Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
title_fullStr	Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
title_full_unstemmed	Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
title_sort	evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: a taiwanese retrospective cohort study.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/a36101caba7b4924a7de216557bb2e84
work_keys_str_mv	AT hsuhengyen evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy AT peiyuansu evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy AT sioupinghuang evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy AT lishawu evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy AT tsuichunhsu evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy AT yahueizeng evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy AT yangyuanchen evaluationofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseaseusingcontrolledattenuationparametertechnologyataiwaneseretrospectivecohortstudy
_version_	1718413761001291776

Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.

Ejemplares similares